相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma
Malak Abedalthagafi et al.
NEURO-ONCOLOGY (2016)
RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors
Xuesong Zhao et al.
CANCER RESEARCH (2015)
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
Giles W. Robinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Tumors with AKT1E17K Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors
Barry R. Davies et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Identification of recurrent SMO and BRAF mutations in ameloblastomas
Robert T. Sweeney et al.
NATURE GENETICS (2014)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2014)
AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry
Felix Sahm et al.
ACTA NEUROPATHOLOGICA (2013)
Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations
Priscilla K. Brastianos et al.
NATURE GENETICS (2013)
Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO
Victoria E. Clark et al.
SCIENCE (2013)
The sonic hedgehog-GLI1 signaling pathway in brain tumor development
Mehdi H. Shahi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring PIK3CA Mutations
Filip Janku et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Aleksandar Sekulic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Endoscopic endonasal skull base surgery: analysis of complications in the authors' initial 800 patients A review
Amin B. Kassam et al.
JOURNAL OF NEUROSURGERY (2011)
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
Dora Dias-Santagata et al.
EMBO MOLECULAR MEDICINE (2010)
Pathological classification and molecular genetics of meningiomas
Christian Mawrin et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma.
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Recurrence and outcome in skull base meningiomas: Do they differ from other intracranial meningiomas?
Anil Nanda et al.
SKULL BASE-AN INTERDISCIPLINARY APPROACH (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Incidence of intracranial meningiomas in Denmark, Finland, Norway and sweden, 1968-1997
L Klaeboe et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Meningioma resection in the elderly: Nationwide inpatient sample, 1998-2002
BT Bateman et al.
NEUROSURGERY (2005)
High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: Long-term results
J Debus et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)